Please login to the form below

Not currently logged in
Email:
Password:

European Cancer Congress 2013

This page shows the latest European Cancer Congress 2013 news and features for those working in and with pharma, biotech and healthcare.

ECC 2013: Nintedanib data boosts Boehringer’s oncology ambitions

ECC 2013: Nintedanib data boosts Boehringer’s oncology ambitions

ECC 2013: Nintedanib data boosts Boehringer’ s oncology ambitions. Lung cancer drug shows extended overall survival in adenocarcinoma patients. ... Data from the LUME-Lung 1 study was presented at the European Cancer Congress in Amsterdam and showed

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Market Access Transformation

Market Access Transformation (MAT), founded by industry veterans Baiju Aurora and Paul Howard, specializes in developing cutting edge technologies that...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics